From: Treatment patterns associated with Duloxetine and Venlafaxine use for Major Depressive Disorder
Characteristic | Duloxetine Group (n = 9,641) | Venlafaxine XR Group (n = 8,514) | p-value |
---|---|---|---|
Age (y), mean ± SD | 45.0 ± 11.4 | 42.4 ± 12.2 | .0001 |
Age group (%) | .0001 | ||
18-35 y | 20.9 | 29.3 | |
36-50 y | 42.6 | 40.9 | |
51-65 y | 36.5 | 29.8 | |
Female (%) | 73.6 | 71.5 | .001 |
Plan type (%) | (NS) | .061 | |
Health maintenance organization | 26.6 | 27.9 | |
Indemnity | 5.4 | 4.7 | |
Preferred provider | 49.9 | 48.7 | |
Point of service | 16.1 | 16.3 | |
Other or unknown | 2.0 | 2.4 | |
Region (%) | .0001 | ||
East | 17.1 | 16.6 | |
Midwest | 39.3 | 43.7 | |
South | 24.1 | 21.4 | |
West | 19.5 | 18.3 | |
Prescribed by psychiatrists (yes vs. no) | 46.2 | 41.8 | .0001 |